tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AZNCF Stock Latest News

Trump’s drug-price crackdown may lead to minor concessions, WSJ reports
The FlyTrump’s drug-price crackdown may lead to minor concessions, WSJ reports
7h ago
CI
AZN
JPMorgan sees ‘most favored nation’ drug order facing ‘significant push back’
PremiumThe Fly
JPMorgan sees ‘most favored nation’ drug order facing ‘significant push back’
24h ago
AZN
GSK
White House publishes Trump executive order aimed at lowering drug prices
PremiumThe Fly
White House publishes Trump executive order aimed at lowering drug prices
1d ago
CI
AZN
AstraZeneca’s Trixeo Aerosphere approved for use in UK with propellant
PremiumThe Fly
AstraZeneca’s Trixeo Aerosphere approved for use in UK with propellant
1d ago
AZN
Trump to sign executive order aimed at lowering drug prices
PremiumThe Fly
Trump to sign executive order aimed at lowering drug prices
2d ago
AZN
BMY
AstraZeneca announces results from POTOMAC trial
PremiumThe FlyAstraZeneca announces results from POTOMAC trial
4d ago
AZN
AstraZeneca announces statistically significant results from POTOMAC trial
Premium
The Fly
AstraZeneca announces statistically significant results from POTOMAC trial
4d ago
AZN
AstraZeneca’s Imfinzi Shows Promise in Bladder Cancer Trial
Premium
Company Announcements
AstraZeneca’s Imfinzi Shows Promise in Bladder Cancer Trial
4d ago
AstraZeneca call volume above normal and directionally bullish
PremiumThe Fly
AstraZeneca call volume above normal and directionally bullish
5d ago
AZN
Pharma imports to U.S. surged in March ahead of tariffs, Reuters says
PremiumThe Fly
Pharma imports to U.S. surged in March ahead of tariffs, Reuters says
6d ago
AZN
BMY
AstraZeneca reports results from DESTINY-Breast11 trial
PremiumThe Fly
AstraZeneca reports results from DESTINY-Breast11 trial
6d ago
AZN
AstraZeneca’s Enhertu Shows Promise in Early-Stage Breast Cancer Trial
PremiumCompany Announcements
AstraZeneca’s Enhertu Shows Promise in Early-Stage Breast Cancer Trial
6d ago
FDA announces expanded use of unannounced inspections at foreign facilities
PremiumThe FlyFDA announces expanded use of unannounced inspections at foreign facilities
7d ago
AZN
BMY
AstraZeneca Calquence approved in EU for treatment of adults with MCL
Premium
The Fly
AstraZeneca Calquence approved in EU for treatment of adults with MCL
7d ago
AZN
Berenberg says pharma ’emerging from the pill penalty box’
Premium
The Fly
Berenberg says pharma ’emerging from the pill penalty box’
7d ago
AZN
LLY
AstraZeneca’s Calquence Approved in EU for First-Line Mantle Cell Lymphoma
PremiumCompany Announcements
AstraZeneca’s Calquence Approved in EU for First-Line Mantle Cell Lymphoma
7d ago
Trump to sign order streamlining U.S. drug manufacturing regulations, WaPo says
PremiumThe Fly
Trump to sign order streamlining U.S. drug manufacturing regulations, WaPo says
8d ago
AZN
BMY
Trump urges drugmakers to accept lower prices on prescriptions, Bloomberg says
PremiumThe Fly
Trump urges drugmakers to accept lower prices on prescriptions, Bloomberg says
8d ago
AZN
BMY
AstraZeneca announces KALOS, LOGOS trials met all primary endpoints
PremiumThe Fly
AstraZeneca announces KALOS, LOGOS trials met all primary endpoints
11d ago
AZN
AstraZeneca announces Phase III KALOS, LOGOS trials met primary endpoints
PremiumThe FlyAstraZeneca announces Phase III KALOS, LOGOS trials met primary endpoints
11d ago
AZN
AstraZeneca’s Breztri Succeeds in Phase III Asthma Trials
Premium
Company Announcements
AstraZeneca’s Breztri Succeeds in Phase III Asthma Trials
11d ago
AstraZeneca Director Invests in Company Shares
Premium
Company Announcements
AstraZeneca Director Invests in Company Shares
12d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >